Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Filter Content:
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Videos
Urology
26 Oct 2022
Recent Advances in the First-Line Management of Advanced Renal Cell Carcinoma: Focus on the Role of Lenvatinib Plus Pembrolizumab Combination Treatment
The 37th Annual European Association of Urology (EAU) Congress 2022 in Amsterdam, the Netherlands, where data from the CLEAR study, a Phase III randomised controlled trial evaluating lenvatinib plus pembrolizumab combination therapy against sunitinib as first-line treatment in patients with advanced renal cell carcinoma, were presented.
Dermatology
25 Oct 2022
Striving for more: personalizing care in patients with psoriatic disease
Striving for more: personalizing care in palients with psoriatic disease. Educational objectives: Understand what patients need and expect from their treatment journey from its outset. Drive the importance of collecting patient reported outcomes on registries and analysing data by gender/age. Consider shared decision-making as essential throughout a patient’s joumey, understanding how it can further treatment personalisation and patient outcomes
Oncology
20 Oct 2022
Breaking Through the Firewall: New Therapeutic Strategies to Disrupt Cancer's Operating Systems
This symposium session presented at the ESMO 2022 included presentations exploring different and new aspects of treating patients.
Respiratory
19 Oct 2022
Global TB Summit 2022: What to expect?
Watch the video to learn more about the annual Global TB Clinical and Educational Summit.
Rheumatology
13 Oct 2022
Current challenges and future perspectives in Juvenile Psoriatic Arthritis and Enthesitis Related Arthritis
As part of Novartis’ continued commitment to medical education in rheumatology. We Invite you to our faculty as they discuss: -The disease state of JPsA and ERA and the impact of diagnosis, clinical features, and disease activity on patients and caregivers. -The importance of both the patient perspective and the unmet needs for optimizing the management of JPsA and ERA -Clinical evidence for IL17 inhibition in the management of ERA and JPsA.
Dermatology
9 Sep 2022
Five Years of World Atopic Dermatitis Day
This podcast mini-series, celebrating World Atopic Dermatitis Day 2022, explores the impact of the global awareness day, looking at how far we have come since its inception 5 years ago.
Dermatology
8 Sep 2022
World AD Day: Progress in patient care and beyond
This video, featuring Professor Stephan Weidinger, celebrates the progress made in the way diseases such as atopic dermatitis are managed via the topic of patient care transformation, as well as the importance of inspiring action to maintain the momentum needed to continue to advance towards multidisciplinary care.
Hematology
5 Sep 2022
Latest updates in Advanced Systemic Mastocytosis from EHA 2022
Latest updates in Advanced Systemic Mastocytosis from EHA 2022. Targeting systemic mastocytosis. Update in Haematology session EHA 2022, Prof. Olivier Hermine introduces the session on overcoming the challenges in diagnosis and management of advanced systemic macrocytosis.
Cardiology
19 Aug 2022
Expert Insights into Updated Advanced HF Management Guidelines Comparing AHA/ACC/HFSA and ESC Guidelines
Discover Professor Antoni Bayés-Genís’ view on the evolution of left ventricular assist devices and his comments related to the AHA/ACC/HFSA guidelines in comparison to the 2021 ESC heart failure guidelines.
Urology
17 Aug 2022
Advancing patient care in the evolving prostate cancer treatment landscape (HYBRID)
This Bayer-sponsored symposium titled ‘Advancing patient care in the evolving prostate cancer treatment landscape (HYBRID)’ took place…
Urology
8 Aug 2022
Broadening our Understanding for Timely Diagnosis and Optimal Treatment of Erectile Dysfunction in COVID-19 Era
The world of sexual health and sexual medicine is rapidly growing with greater awareness on human sexuality, and the integration of novel technologies in healthcare practices.
Urology
11 Jul 2022
The latest advances in prostate cancer research
On the final day of EAU22 in Amsterdam, experts stepped away from the action to present highlights in prostate cancer treatment from this year’s congress.
Gastroenterology
30 Jun 2022
Would you suspect AIP?
A real-life, severe case study of AIP by Professor Ulrich Stoelzel. Video developed and funded by Alnylam Pharmaceuticals
Neurology
30 Jun 2022
Would you suspect AIP?
A real-life, severe case of AIP by Professor Jean-Charles Deybach, MD PhD. Video developed and funded by Alnylam Pharmaceuticals.
General Healthcare
28 Jun 2022
Novartis-sponsored EULAR 2022 scientific symposium - Making the invisible visible in PsA and axSpA
In this symposium, Prof. Georg Schett, Prof. Denis Poddubnyy Dr. Raj Sengupta and Prof. Maria-Antonietta D’Agostino discuss: Impact and…
Oncology
15 Jun 2022
Management of patients with oncogene-driven NSCLC: the shift towards personalized medicine
Discuss the importance of the implementation of biomarker testing in routine clinical practice and the current and future challenges…
Hematology
13 May 2022
Jazz-Sponsored Symposium - High-risk AML* in 2022: what is the go-to strategy?
*High-risk AML defined as therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC)
Interventional Cardiology
26 Apr 2022
When you choose Angiolite, you know who stands by you
Know more about Angiolite and the people who make it possible, because when you choose Angiolite, you know who stands by you…
Dermatology
11 Jan 2022
Unlocking the potential of immuno-oncology in advanced basal cell carcinoma
This symposium covers unmet needs in the treatment approach and management of advanced BCC. There is no standard…
Dermatology
15 Nov 2021
The Complete Management of Psoriatic Disease in a COVID World
In this opening video, which includes a patient’s perspective of living with psoriasis, Professor Diamant Thaçi (Chair) begins with his opening remarks and introductions, and gives an overview of the agenda.
Reproductive Health
20 Oct 2021
Interview with Prof. Neil Johnson
Professor of Reproductive Health, Robinson Research Institute, Adelaide Gynecologist and REI Subspecialist, Auckland Gynecology Group and Repromed Auckland
Oncology
15 Oct 2021
Navigating the Current Treatment Landscape in Esophageal Cancer with an Eye Toward the Future
Novartis sponsored ESMO 2021 Satellite Symposium: Navigating the Current Treatment Landscape Faculty: Prof Eric…
Hematology
30 Sep 2021
ESMO 2021 Jazz Pharmaceuticals AML symposium
Insight beyond Phase 3: Does real-world evidence impact how we treat high-risk AML…
Rheumatology
26 Jul 2021
Reimagining patient care and future direction in Axial Spondyloarthritis and Psoriatic Arthritis
In this session chaired by Prof. Baraliakos, Prof. Nash and Prof. Machado discuss advances in artificial intelligence and machine learning that could potentially aid in the diagnosis and management of axSpA and PsA.
Rheumatology
26 Jul 2021
Reimagining the standard of care in Psoriatic Arthritis and Axial Spondyloarthritis
In this short summary video, Prof. Gottlieb discusses the role dermatologists can play in detecting PsA as well as the diagnostic tools that can be used to help achieve an early diagnosis.
Rheumatology
26 Jul 2021
Meet the expert: Managing Axial Psoriatic Arthritis
In this short summary video, Prof. Mease discusses the need for consensus on the definition and classification criteria for the axial manifestation of PsA, also highlighting the need for specific clinical assessments and clinical trials designed to investigate the efficacy of therapy options in this patient population.
Hepatology
16 Jun 2021
Liver transplant patients with HBV-related hepatocellular carcinoma
Prof. Patrizia Burra (Italy) and Prof. Ramazan Idilman (Turkey) are sharing their experience with and knowledge about HBV-related liver transplant patients with hepatocellular carcinoma including epidemiology, risk factors for HBV recurrence and current therapy.
Urology
24 Aug 2020
Master Class in Bladder Cancer: Practical Solutions to Common Scenarios in NMIBC
‘Master class in bladder cancer: practical solutions to common scenarios in NMIBC’ was the title of a specialist satellite symposium held virtually…
Gastroenterology
18 May 2020
AbbVie Symposium at ECCO 2020: The Illusion of Remission
“The Illusion of Remission,” presented at the 15th congress of the European Crohn’s and Colitis Organisation (ECCO) in Vienna, Austria, included…
Gastroenterology
5 May 2020
Jonathan Sackier and Steven D. Wexner Interview: ICDS
Dr Jonathan Sackier sat down with Prof Steve Wexner, organiser of the highly successful 2020 International Colorectal DIsease Symposium in Jerusalem…
Gastroenterology
30 Apr 2020
An Interview with Prof Alberto Arezzo at UEG Week Barcelona 2019
We spoke to Prof Alberto Arezzo (UEG Scientific Committee Member) at UEG Week 2019, Barcelona, Spain, where he discussed developments in surgical…
General Healthcare
29 Apr 2020
An Interview with Rodrigo Gribble from AstraZeneca
We met with Rodrigo Gribble, Vice President, Cardiovascular, AstraZeneca, who discussed his experience working with emerging markets, the recent successes…
Gastroenterology
24 Apr 2020
ICDS Interview with Professor Abe Fingerhut
We sat down with Prof Abe Fingerhut at the ICDS to discuss his long and illustrious career in colorectal surgery.
Gastroenterology
17 Apr 2020
ICDS Interview with Dr Miklosh Bala
Dr Jonathan Sackier sat down with Dr Miklosh Bala to discuss, among other things, trauma surgery in the Israeli capital of Jerusalem.
Gastroenterology
15 Apr 2020
An interview with Prof Janneke van der Woude at UEG Week Barcelona 2019
We spoke to Prof Janneke van der Woude (UEG General Gastroenterology Representative) at UEG Week 2019…
Gastroenterology
9 Apr 2020
An interview with Prof Paul Fockens at UEG Week Barcelona 2019
We spoke to Prof Paul Fockens (UEG President) at UEG Week 2019, Barcelona, Spain…
Oncology
2 Apr 2020
Second AACR International Meeting: Advances in Malignant Lymphoma
Second AACR International Meeting: Advances in Malignant Lymphoma: Maximizing the Basic-Translational Interface for Clinical Application held in…
Gastroenterology
2 Apr 2020
EMJ: Ron Landmann interview at ICDS 2020
Speaking to us at the 2020 Israel International Colorectal Disease Symposium, Dr Ron Landmann, Chief of Division of Colorectal Surgery/Surgical Oncology…
Gastroenterology
26 Mar 2020
An Interview with Prof Manish Chand in Lead-up to the International Colorectal Disease Symposium
Speaking to us in the lead-up to the 2020 Israel International Colorectal Disease Symposium, Prof Manish Chand…
Gastroenterology
10 Mar 2020
An Interview with Prof Jonathan Sackier at the International Colorectal Disease Symposium 2020
Spencer Gore, CEO of EMG-Health, speaks to Professor Jonathan Sackier at the International Colorectal Disease Symposium in Israel about EMG-Health…
Respiratory
26 Feb 2020
ERS 2019 Interview: Prof Jacques Cadranel
An interview with Prof Jacques Cadranel, Faculty Director, Service de Pneumologie, Hôpital Tenon, Paris, France, at the 2019 ERS Congress…
Cardiology
27 Nov 2019
ESC 2019 – Interview – Dr Çetin Erol
An interview with Dr Çetin Erol, İbn-i Sina Hospital, Faculty of Medicine, Department of Cardiology, Ankara University, Ankara, Turkey, at this year’s ESC…
Cardiology
25 Nov 2019
ESC 2019 – Interview – Dr Donald Lloyd-Jones
An interview with Dr Donald Lloyd-Jones, Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Illinois, USA.
Reproductive Health
2 Sep 2019
ESHRE 2019 – Interview – Prof Claire Roberts
An interview with Prof Claire Roberts, Lloyd Cox Professorial Research Fellow, University of Adelaide, at this year’s ESHRE congress in Vienna, Austria…
Oncology
29 Aug 2019
Comprehensive Genomic Profiling (CGP) Enabled by Next-Generation Sequencing Technology
CGP enabled by next-generation sequencing (NGS) technology allows all known biomarkers to be evaluated in a single test.
General Healthcare
28 Aug 2019
An interview with Sam Glassenberg from Level Ex
We recently met with Sam Glassenberg, Founder and CEO, Level Ex, at the 2019 Cannes Lions Festival of Creativity…
Gastroenterology
20 Aug 2019
ECCO 2019 – Interview – Dr Frank Behrens
An interview with Dr Frank Behrens, Medical Director of the Centre of Innovative Diagnostics and Therapeutics Rheumatology/Immunology Goethe-University…
Reproductive Health
16 Aug 2019
ESHRE 2019 – Interview – Prof Michael Grynberg
An interview with Prof Michael Grynberg, Head, Department of Reproductive Medicine & Fertility Preservation, Hôpital Antoine Béclère, at this year’s ESHRE…
General Healthcare
14 Aug 2019
An interview with Daniel Carucci, McCann Health
We recently met with Daniel Carucci, Global Medical Director, McCann Health, at the 2019 Cannes Lions Festival of Creativity. Daniel discusses…
General Healthcare
31 Jul 2019
An interview with Susan Manber from Digitas Health
We recently met with Susan Manber, Chief Strategy Officer, Digitas Health, at the 2019 Cannes Lions Festival of Creativity…
General Healthcare
23 Jul 2019
An interview with Andrea Palmer from Publicis Health Media
We recently met with Andrea Palmer, President of Publicis Health Media at the 2019 Cannes Lions Festival of Creativity. In this interview Andrea talks about the new generation of HCP and how the pharma industry can meet the changing consumer expectations, as well as her own career and leadership success.
General Healthcare
7 Jun 2019
An interview with Isabel Torres from Takeda
We met with Isabel Torres, General Manager Finland, Takeda, at eyeforpharma Barcelona 2019 to talk about where the greatest opportunities lie in value-based healthcare, as well as initiatives that Isabel has been a part of, which really go beyond the medicine.
General Healthcare
13 May 2019
An interview with Thomas D'Hooghe from Merck
An interview with Thomas D’Hooghe, VP and Head Global Medical Affairs Fertility, Merck KGaA, Darmstadt, Germany at this year’s eyeforpharma, Barcelona Conference. We speak to Thomas about advancements in the fields of fertility and assisted reproductive technology as well as pharma’s role in providing world-class endometriosis care to all.
Gastroenterology
29 Apr 2019
“Defining the Future of IBD Care: The Pivotal Role of Personalized Treatment” – ECCO 2019
In this interactive symposium, presented at the 14th Congress of ECCO in Copenhagen, Denmark, on 8th March 2019, the faculty shared key insights into…
General Healthcare
24 Apr 2019
An Interview with John Zibert from LEO Innovation Lab
An interview with John Zibert, Chief Medical Officer, Medical Director, LEO Innovation Lab at this year’s eyeforpharma, Barcelona Conference. We speak to John about the vision LEO Innovation Lab created for itself when it launched in 2015 and the potential of non-pharmaceutical based solutions in healthcare.
Urology
23 Apr 2019
EAU 2019 - Congress Highlights
Our full congress review of EAU 2019 will be available one week today on the 30 April in Urology 7.1! While you wait, here is a look into the congress centre Gran Via in Barcelona, Spain. For more on urology take a look at our published articles: https://www.emjreviews.com/therapeutic-area/urology/
Urology
18 Apr 2019
EAU 2019 - Opening Ceremony
Our full congress review of EAU 2019 will be available soon for free in our Urology 7.1 eJournal, but here is a look at the opening ceremony while you wait..
General Healthcare
17 Apr 2019
An Interview with Kabir Nath from Otsuka
An interview with Kabir Nath, President and CEO, Otsuka North America at this year’s eyeforpharma, Barcelona conference. We speak to Kabir about Otsuka’s collaboration with Proteus Digital Health as well as the company’s unique set of values.
Urology
16 Apr 2019
EAU 2019 - Interview - Prof Hendrik Van Poppel
An interview with Prof Hendrik Van Poppel, Chairman of the Scientific Committee of Europa Uomo, Board Member of European Cancer Organisation on…
General Healthcare
11 Apr 2019
An Interview with Roslyn Schneider
An interview with Roslyn Schneider, Former Global Patient Affairs Lead, Pfizer, at this year’s eyeforpharma, Barcelona conference.
General Healthcare
9 Apr 2019
An Interview with Kasper Jerlang from LEO Pharma
An interview with Kasper Jerlang, Head of Global Digital Marketing and Engagement, LEO Pharma, at this year’s eyeforpharma, Barcelona conference. Kasper speaks about his role in digital marketing at LEO as well as the company culture and his approach to leadership.
General Healthcare
23 Jan 2019
An Interview with Heather Moses from Roche
An interview with Heather Moses, Head of Medical Affairs, Roche Products Ltd. We met with Heather at the Roche Hub, Welwyn Garden City, where Heather provided insight on the current and evolving landscape of Medical Affairs, as well as a personal perspective on senior leadership within the life-sciences industry.
General Healthcare
28 Nov 2018
An Interview with Daniel De Schryver from Janssen
An interview with Daniel De Schryver, Patient Engagement & Advocacy Lead, EMEA, Janssen Pharmaceutical Companies of Johnson & Johnson at the eyeforpharma Patient Summit, Europe. Daniel talks about overcoming fear to create a genuine dialogue that will make better solutions for patients and how his past experiences have helped shape his leadership today.
General Healthcare
23 Nov 2018
An Interview with Asad Mohsin Ali from Ipsen
An interview with Asad Mohsin Ali, General Manager UK and Ireland, Ipsen, who talks about how pharmaceutical companies can add value and why market access is becoming a hot topic.
Gastroenterology
16 Nov 2018
UEG Week 2018 - Congress Highlights
Don’t miss out on this year’s UEG Week annual congress, with our quick-look into the Austria Center Vienna venue in Vienna, Austria.
Oncology
16 Nov 2018
ESMO 2018 - Congress Highlights
Catch up on this year’s European Society for European Society for Medical Oncology (ESMO) annual congress, with our inside look at the Internationales…
Diabetes
16 Nov 2018
EASD 2018 - Congress Highlights
Grab a sneak peek into this year’s European Association for the Study of Diabetes (EASD) annual congress, in our congress highlights from Messe Berlin…
Respiratory
16 Nov 2018
ERS 2018 - Congress Highlights
Take a look into the home of this year’s European Respiratory Society’s (ERS) annual congress, in our short video of the Paris Expo Porte de Versailles…
General Healthcare
8 Nov 2018
An interview with Philippe Kirby from MSD
An interview with Philippe Kirby, Customer Engagement Capabilities Director, MSD, at the eyeforpharma Marketing and Customer Innovation, Europe. Kirby discusses the power of data and digital in delivering a personalised customer experience as well as what inspires him within and outside the industry.
Dermatology
29 Oct 2018
EADV 2018 - Congress Highlights
Dive into the venue of this year’s European Academy of Dermatology and Venerology (EADV) annual congress, in our inside look at Messe München GmbH in…
General Healthcare
10 Oct 2018
An interview with Giles Platford from Takeda
An interview with Giles Platford, President Europe & Canada, Takeda Pharmaceutical Company Limited at the eyeforpharma conference, Barcelona, 2018. Mr Platford discusses Takeda’s Patient-Trust-Reputation-Business decision-making model to ensure the patient is at the heart of everything and what it takes to successfully manage a team and inspire innovation, while striving for sustainable business growth.
Cardiology
6 Sep 2018
ESC 2018 - Congress Highlights
Join us and catch a brief glimpse into the venue of this year’s European Society of Cardiology (ESC) annual congress, in our inside look at Messe München…
Reproductive Health
30 Aug 2018
ESHRE 2018 - Interview - Prof Klaus Dugi
An interview with Prof Klaus Dugi (Chief Medical Officer and Executive Vice President, Ferring) at this year’s ESHRE Congress held in Barcelona, Spain.
Reproductive Health
28 Aug 2018
ESHRE 2018 - Interview - Dean Morbeck
An interview with Dean Morbeck (Scientific Director, Fertility Associates, Auckland, New Zealand) at this year’s ESHRE Congress held in Barcelona, Spain.
Reproductive Health
28 Aug 2018
ESHRE 2018 - Interview - Dr Elena Labarta
An interview with Dr Elena Labarta (Gynaecologist, IVI Clinic Valencia, Valencia, Spain) at this year’s ESHRE Congress held in Barcelona, Spain.
Reproductive Health
14 Aug 2018
ESHRE 2018 - Congress Highlights
Dive into the venue of this year’s ESHRE 2018 congress, held in the Barcelona International Conference Center, Barcelona, Spain.
General Healthcare
10 Aug 2018
An interview with Atilla Cansun from Merck Consumer Health
An interview with Atilla Cansun, Chief Marketing Officer, Merck Consumer Health, at Cannes Lions 2018, who talks building successful brands, multichannel…
Neurology
6 Aug 2018
EAN 2018 - Congress Highlights
Experience the home of the European Academy of Neurology’s (EAN) annual congress 2018, in our behind the scenes look at this year’s Lisbon Congress…
Hematology
2 Aug 2018
NGS in PH+ LEUKEMIA: WATCH AN INTERVIEW WITH DR SOVERINI
Dr Simona Soverini discusses early molecular response, next-generation sequencing, and the impact of tyrosine kinase inhibitor-resistant mutations in…
General Healthcare
1 Aug 2018
An interview with Gwenan White from AbbVie
An interview with Gwenan White, UK Director of Communications, AbbVie, at Cannes Lions 2018, who discusses how pharma can work in the preventative health…
General Healthcare
26 Jul 2018
An Interview with Eric Peacock from MyHealthTeams
An interview with Eric Peacock, Co-Founder and CEO of MyHealthTeams, at Cannes Lions 2018 who discusses patient engagement through social networks and…
Rheumatology
24 Jul 2018
EULAR 2018 - Congress Highlights
Delve into the venue for this year’s European League Against Rheumatism (EULAR) Congress.
Hematology
24 Jul 2018
EHA 2018 - Congress Highlights
Delve into the venue for this year’s European Hematology Association (EHA) Congress.
Allergy & Immunology
16 Jul 2018
EAACI 2018 – Interview – Dr Stefan Wöhrl
An interview with Prof Nikos Papadopoulos (University of Manchester, UK) at this year’s EAACI Congress held in Munich, Germany.
Allergy & Immunology
16 Jul 2018
EAACI 2018 – Interview – Dr Stefan Wöhrl
An interview with Dr Stefan Wöhrl (Floridsdorf Allergy Center (FAZ), Austria) at this year’s EAACI Congress held in Munich, Germany.
Allergy & Immunology
16 Jul 2018
EAACI 2018 - Interview - Dr Enrico Heffler
An interview with Dr Enrico Heffler (Humanitas University, Italy) at this year’s EAACI Congress held in Munich, Germany.
Allergy & Immunology
16 Jul 2018
EAACI 2018 - Congress Highlights
Take a short look at the venue for this year’s European Academy of Allergy and Clinical Immunology (EAACI) Congress.
Interventional Cardiology
4 Jul 2018
EuroPCR 2018 - Congress Highlights
Step centre stage into our congress highlights, and get an insight into the venue of this year’s EuroPCR annual meeting.
General Healthcare
13 Jun 2018
An Interview with Houda Kamoun from Aptus Health
An interview with Houda Kamoun, Chief Strategy & Marketing Officer, Aptus Health at eyeforpharma, Barcelona 2018 who shares her insights…
General Healthcare
8 Jun 2018
An interview with Shreeram Aradhye from Novartis
An interview with Shreeram Aradhye, Chief Medical Officer and Global Head, Novartis Pharmaceuticals at eyeforpharma, Barcelona 2018 who discusses….
General Healthcare
8 Jun 2018
An interview with Amy Nicole Nayar from AbbVie
An interview with Amy Nicole Nayar, Head of Global Patient Relations, AbbVie at eyeforpharma, Barcelona 2018 who discusses the place of the patient…
Hepatology
31 May 2018
ILC 2018 - Congress Highlights
Here’s a look into the venue of this year’s International Liver Congress (ILC), for the 53rd annual meeting.
Hepatology
31 May 2018
ILC 2018 - Interview - Dr Dhiraj Tripathi
An interview with Dr Dhiraj Tripathi (Queen Elizabeth Hospital Birmingham, UK) at this year’s ILC congress held in Paris, France.
Urology
8 May 2018
EAU 2018 - Congress Highlights
Here we present a brief look into this year’s European Association of Urology (EAU) congress, for their 33rd annual meeting.
Oncology
9 Feb 2018
Progress in the treatment of chronic lymphocytic leukaemia
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Jeremy S. Abramson, MD, of the Massachusetts General Hospital Cancer Center…
Oncology
9 Feb 2018
New trials for cancer patients at Sarah Cannon Research Institute
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Hendrik-Tobias Arkenau, MD, PhD, of Sarah Cannon Research Institute, UK…
Gastroenterology
25 Jan 2018
News Update: CALM Study Results
A presentation summarising the design and results from the CALM study, which compared the tight control approach with symptom-driven care in patients…
Gastroenterology
25 Jan 2018
Treating to Target in Inflammatory Bowel Disease: At What Cost?
A presentation summarising the clinical benefits of the treat to target approach in inflammatory bowel disease, particularly reflecting on the changes in…
Gastroenterology
25 Jan 2018
AbbVie Symposium at UEGW 2017: Keep CALM and Treat to Target in Inflammatory Bowel Disease
A symposium highlighting the importance of early diagnosis, assessing prognostic factors, and treating to target in patients with inflammatory…
Gastroenterology
25 Jan 2018
In Focus: Importance of Early Diagnosis and Treating to Target in Inflammatory Bowel Disease
A presentation highlighting the importance of treating inflammatory bowel disease early and stratifying patients for a personalised therapeutic strategy…
Respiratory
15 Jan 2018
Home Non-Invasive Ventilation for Patients with Severe COPD
ERS 2017 – Evening Symposium: Milan, 11 September, 2017
Respiratory
15 Jan 2018
The Importance of Activity for COPD Patients: Clinical Evidence and Solutions to Support It
ERS 2017 – Evening Symposium: Milan, 11 September. Prof Dr Klaus Kenn.
Respiratory
15 Jan 2018
Home NIV in COPD: From Screening to Patient Follow up, Available Tools and Perspectives
ERS 2017 – Evening Symposium: Milan, 11 September, 2017 (Session 3 of 4)
Respiratory
15 Jan 2018
How Home Therapy Devices Can Improve the Outcome of COPD Patients: Panel Question & Answer
ERS 2017 – Evening Symposium: Milan, 11 September, 2017
Dermatology
30 Nov 2017
Tackling the Inflammatory Burden of Psoriasis: A Multidisciplinary Approach
The symposium took place on 15th September 2017 as part of the European Academy of Dermatology and Venereology (EADV) Congress in Geneva, Switzerland.
Cardiology
19 Sep 2017
ESC 2017 – Opening Ceremony
Our full congress review of ESC 2017 will be available soon for free in our Cardiology 5.1 eJournal, but here is a look at the opening ceremony while you…
Cardiology
19 Sep 2017
ESC 2017 – Congress Highlights
Here is a look at this year’s congress highlights, and grab our full congress review of ESC 2017 in EMJ’s Cardiology 5.1 eJournal, coming soon.
Reproductive Health
12 Sep 2017
ESHRE 2017 – Interview – Dr Arianna D’Angelo
An interview with Dr Arianna D’Angelo (Fertility Institute-Cardiff University, UK) at this year’s ESHRE congress held in Geneva, Switzerland.
Reproductive Health
5 Sep 2017
ESHRE 2017 – Congress Highlights
Here is a look at this year’s congress highlights, and grab our full congress review of ESHRE 2017 in EMJ’s Reproductive Health 3.1 eJournal…
Hematology
5 Sep 2017
EHA 2017 – Interview – Prof Emanuele Angelucci
An interview with Prof Emanuele Angelucci (Istituto di Ricovero e Cura a Carattere Scientifico, Italy) at this year’s EHA congress held in Madrid, Spain.
Rheumatology
29 Aug 2017
EULAR 2017 – Interview – Dr João Fonseca
An interview with Dr João Fonseca (Lisbon Academic Medical Centre, Portugal) at this year’s EULAR congress held in Madrid, Spain.
Hematology
29 Aug 2017
EHA – 2017 – Congress Highlights
Grab our full congress review of EHA 2017 in EMJ’s Hematology 5.1 eJournal. In the meantime take a look at this year’s congress highlights.
Hematology
29 Aug 2017
EHA 2017 – Opening Ceremony
Our full congress review of EHA 2017 is now available for free in our Hematology 5.1 eJournal, and here is a look at the opening ceremony.
Allergy & Immunology
29 Aug 2017
EAACI 2017 – Interview – Prof Maria Jose Torres
An interview with Prof Maria Jose Torres (Malaga Regional University Hospital, Spain) at this year’s EAACI congress held in Helsinki, Finland.
Allergy & Immunology
29 Aug 2017
EAACI 2017 – Interview – Dr Enrico Heffler
An interview with Dr Enrico Heffler (Humanitas University, Italy) at this year’s EAACI congress held in Helsinki, Finland.
Hematology
4 Aug 2017
More Frequent Haemodialysis Improved Outcomes: The Wish Comes True at Home
This satellite symposium reviewed the challenges in providing dialysis to patients with kidney disease and outlined data supporting the effectiveness of…
Rheumatology
31 Jul 2017
EULAR 2017 – Congress Highlights
Our full congress review of EULAR 2017 is out now! Find it for free in our Rheumatology 4.1 eJournal. Take a look at some of the sights from this year’s…
Interventional Cardiology
18 Jul 2017
EuroPCR 2017 – Congress Highlights
Our full congress review of EuroPCR 2017 is out now in our Interventional Cardiology 5.1 eJournal, and here we present a look at the highlights…
Neurology
17 Jul 2017
Basal Forebrain Atrophy and Elevated Plasmatic Homocysteine Levels in Dementia Patients
Ondrej Lerch, MD from Charles University in Prague, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic discusses a study…
Interventional Cardiology
17 Jul 2017
EuroPCR 2017 – Opening Ceremony
Our full congress review of EuroPCR 2017 is out now in our Interventional Cardiology 5.1 eJournal, and here we give you a look into the opening ceremony…
Oncology
13 Jul 2017
ASSIST-FL – Primary Outcome: Interview with Prof. Jurczak
In this interview, Professor Wojciech Jurczak presents and discusses the primary results of ASSIST-FL, the confirmatory, PhIII randomised, double blinded…
Neurology
7 Jul 2017
Atypical Parkinsonian Disorders
Kailash P. Bhatia, MD, DM, FRCP from the University College London, London, UK talks about atypical parkinsonian disorders. This interview was recorded…
Nephrology
7 Jul 2017
Cognitive Performance of Patients with Chronic Kidney Disease
Janine Gronewold, PhD from the University Hospital Essen, Essen, Germany provides an overview of a study on the cognitive performance of patients with…
Neurology
7 Jul 2017
ALS and FTD: Pathomechanistically Related Conditions?
Manuela Neumann, MD from the University Hospital Tuebingen, Tuebingen, Germany outlines the neuropathology and genetics of amyotrophic lateral sclerosis…
Neurology
7 Jul 2017
Arterial Spin Labeling MRI: A Potential Early Biomarker for Alzheimer’s Disease
M. Hale Alpsan Gökmen, MD from the Anadolu Health Center, Gebze, Turkey talks about arterial spin labeling (ASL) MRI and if it can be used as a method…
Neurology
7 Jul 2017
Parental Family History of Dementia and Its Association with Risk of Developing Dementia
Frank Wolters, MD from the Erasmus Medical Center, Rotterdam, Netherlands outlines a study on parental family history of dementia and its association…
Neurology
7 Jul 2017
LTP-Like Cortical Plasticity as a Novel Biomarker of Alzheimer’s Disease Progression
Francesco Di Lorenzo, MD from the Santa Lucia Foundation IRCCS, Rome, Italy discusses a study looking at LTP-like cortical plasticity as a novel…
Neurology
7 Jul 2017
The Management of Vascular Cognitive Impairment
Leonardo Pantoni, MD, PhD from the University of Florence, Florence, Italy discusses vascular cognitive impairment and its management…
Neurology
7 Jul 2017
How Alzheimer’s Disease Biomarkers Are Affected by Physical Activity
Kristian Steen Frederiksen, MD, PhD from the Danish Dementia Research Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark discusses…
Neurology
7 Jul 2017
Genetic Counselling for Alzheimer’s Disease and Frontotemporal Dementia
Daniela Galimberti, PhD from the University of Milan, Milan, Italy discusses genetic counselling for Alzheimer’s disease and frontotemporal dementia…
Oncology
15 Jun 2017
Prof. Marie-Pia d’Ortho Interview
Interview with Prof. Marie-Pia d’Ortho.
Respiratory
15 Jun 2017
The Clinical Use of ASV – What Have We Learned Lately?
Anita Simonds explains the latest clinical evidences about ASV.
Cardiology
15 Jun 2017
What’s Happened and Where next for ASV? In Heart Failure and Out of Heart Failure
Anita Simonds explains the latest clinical evidences about ASV in Heart Failure.
Respiratory
15 Jun 2017
Other Key Areas of Interest for ASV, Complex Sleep Apnea and Treatment Emergent CSA: CSA in Non-Cardiac Patients; Opioid Induced SDB
Anita Simonds explains the usage of ASV in the other areas of interest of Heart Failure.
Cardiology
15 Jun 2017
Clinical Case of Sleep Disordered Breathing in a Patient with Heart Failure and Reduced Ejection Fraction (HFrEF)
Michael Arzt presents a clinical case of ASV in the SERVE-HF population.
Respiratory
15 Jun 2017
Clinical Case of ASV in a Patient with Opioids Induced Central Sleep Apnea
Michael Arzt presents a clinical case of ASV in opioid induced CSA.
Cardiology
15 Jun 2017
Clinical Case of ASV in a Patient with Heart Failure and Preserved Ejection Fraction
Michael Arzt presents a clinical case of ASV in HFpEF.
Respiratory
15 Jun 2017
Management of SDB with Adaptive Servo Ventilation
Symposium at the Sleep&Breathing meeting in April 2017 in Marseille (France).
Rheumatology
12 Jun 2017
Professor Edwards’ Invitation to Biogen’s Satellite Symposium at EULAR 2017
Video Invitation from Chris Edwards (Professor of Clinical Rheumatology, University of Southampton, UK) to Biogen’s Satellite Symposium at EULAR 2017…
Cardiology
5 Jun 2017
ILC 2017 – Interview – Dr Ahmed Elsharkawy
An interview with Dr Ahmed Elsharkawy (University Hospirals Birmingham, UK) at this year’s ILC congress held in Amsterdam, Netherlands.
Hepatology
5 Jun 2017
ILC 2017 – Opening Ceremony
Our full congress review of ILC 2017 is out now in our Hepatology 5.1 eJournal, and here we give you a look into the opening ceremony.
Hepatology
5 Jun 2017
ILC 2017 – Congress Highlights
Our full congress review of ILC 2017 is out now in our Hepatology 5.1 eJournal, and here we present a look at the highlights.
Respiratory
22 May 2017
HOT-HMV: Study objective, methodology and results – Dr. Patrick Murphy
ERS 2016 – Evening Symposium: London, 6 September. Home non-invasive ventilation for COPD patients: New perspectives from the HOT-HMV trial
Respiratory
22 May 2017
Lessons learned from HOT-HMV: techniques and monitoring – Prof. Nicholas Hart
ERS 2016 – Evening Symposium: London, 6 September. Home non-invasive ventilation for COPD patients: New perspectives from the HOT-HMV trial
Respiratory
22 May 2017
Home NIV for COPD – where are we now with the evidence – Prof Michael Dreher
ERS 2016 – Evening Symposium: London, 6 September Home non-invasive ventilation for COPD patients: New perspectives from the HOT-HMV trial
Respiratory
22 May 2017
HOT-HMV study: Panel discussion and Q&A
ERS 2016 Evening Symposium: Home Non-Invasive Ventilation for COPD patients: New perspectives from the HOT-HMV Trial – London, 6 September
Urology
24 Apr 2017
EAU 2017 – Congress Highlights
Our full congress review of EAU 2017 will be available soon in our Urology 5.1 eJournal, but for now take a look at the highlights from this year’s event…
Urology
24 Apr 2017
EAU 2017 – Interview – Dr Riccardo Autorino
An interview with Dr Riccardo Autorino (Case Medical Center, USA) at this year’s EAU congress held in London, UK.
Respiratory
8 Dec 2016
Use of NIV in COPD Patients
During this presentation Prof. Dr. Dreher shares his insights in the management of the COPD patient after an acute exacerbation.
Respiratory
8 Dec 2016
Challenging Clinical Cases in Pulmonology
Experts present clinical cases, share their practical insights in the diagnosis and management of patients with respiratory diseases.
General Healthcare
8 Dec 2016
Challenging Clinical Cases in Sleep Medicine
Nordic Master Class, Stockholm Sweden, November 8-10, 2016. Round table discussion where experts present thought-provoking clinical cases
Respiratory
8 Dec 2016
New Horizons in ASV
Prof Simonds comments on the results of the SERVE-HF trial and also discusses the different uses of ASV as therapy for complex sleep apnoea, central…
Respiratory
8 Dec 2016
Adaptive Servo Ventilation – What’s next? by Anita K. Simonds
We bring you a recording of a discussion by a panel of experts entitled New Horizons in ASV: Advancing science | informing ASV clinical practice. ASV has…
Dermatology
21 Nov 2016
Will Biosimilars Change the Treatment Paradigm in Psoriasis?
This symposium took place on 29th September 2016 as a part of the European Academy of Dermatology and Venereology (EADV) Congress in Vienna, Austria…
Gastroenterology
31 Oct 2016
An interview with Julie Iven at UEG Week Vienna 2016
An interview with Julie Iven (Translational Research Center for Gastrointestinal Disorders) at UEG Week Vienna 2016, Austria.
Gastroenterology
31 Oct 2016
An interview with Dr Jan Tack at UEG Week Vienna 2016
An interview with Dr Jan Tack (Professor of Gastroenterology, University Hospital of Leuven) at UEG Week Vienna 2016, Austria.
Gastroenterology
31 Oct 2016
An interview with Dr Dina Tiniakos at UEG Week Vienna 2016
An interview with Dr Dina Tiniakos (Clinical Senior Lecturer/Hon, Consultant in Cellular Pathology) at UEG Week Vienna 2016, Austria.
Gastroenterology
31 Oct 2016
An interview with Prof Janneke van der Woude at UEG Week Vienna 2016
An interview with Prof Janneke van der Woude (Gastroenterology and Liver Department, Erasmus MC, Rotterdam) at UEG Week Vienna 2016, Austria.
Gastroenterology
31 Oct 2016
Congress Review – UEG Week Vienna 2016
Don’t miss our congress review in our EMJ Gastroenterology 5.1 2016 eJournal, coming soon…
Diabetes
26 Oct 2016
Congress Review – EASD 2016
Read our congress review in our EMJ Diabetes 4.1 2016 eJournal, available now…
Diabetes
26 Oct 2016
An interview with Prof Dr Coen Stehouwer at the 2016 EASD Congress
An interview with Prof Dr Coen Stehouwer (Professor of Medicine and Chair, Department of Internal Medicine) at the 2016 EASD Congress, Munich, Germany.
Diabetes
26 Oct 2016
An interview with Prof Vilma Urbančič-Rovan at the 2016 EASD Congress
An interview with Prof Vilma Urbančič-Rovan (Head of the Diabetes Unit, University Medical Centre Ljubljana) at the 2016 EASD Congress, Munich, Germany.
Dermatology
26 Oct 2016
An interview with Prof Chris Griffiths at the 2016 EADV Congress
An interview with Prof Chris Griffiths (Professor of Dermatology, University of Manchester) at the 2016 EADV Congress, Vienna, Austria.
Dermatology
26 Oct 2016
An interview with Prof Torello M. Lotti at the 2016 EADV Congress
An interview with Prof Torello M. Lotti (Professor and Chair of Dermatology, University of Rome) at the 2016 EADV Congress, Vienna, Austria.
Dermatology
26 Oct 2016
Congress Review – EADV 2016
Don’t miss our congress review in our EMJ Dermatology 4.1 2016 eJournal, coming soon…
Diabetes
26 Oct 2016
An interview with Dr Lorenzo Pasquali at the 2016 EASD Congress
An interview with Dr Lorenzo Pasquali (Junior Group Leader, Department of Endocrinology) at the 2016 EASD Congress, Munich, Germany.
Urology
29 Sep 2016
GreenLight XPS™Laser Therapy System: A True Day Case Procedure
The National Institute for Clinical Health Care and Excellence (NICE) has given favourable guidance for GreenLight XPS™, advising that is Cost Saving…
Cardiology
27 Sep 2016
An interview with Dr Carl Lavie at the 2016 ESC Congress
An interview with Dr Carl Lavie (Medical Director, Cardiac Rehabilitation and Prevention) at the 2016 European Society of Cardiology Congress, Rome, Italy.
Cardiology
27 Sep 2016
An interview with Dr Javed Butler at the 2016 ESC Congress
An interview with Dr Javed Butler (Chief of the Cardiology Division, Stony Brook University) at the 2016 European Society of Cardiology Congress, Rome…
Cardiology
27 Sep 2016
An interview with Dr Bill Sasiela at the 2016 ESC Congress
An interview with Dr Bill Sasiela (Regeneron Pharmaceuticals, New York, USA) at the 2016 European Society of Cardiology Congress, Rome, Italy.
Cardiology
27 Sep 2016
An interview with Dr Jay Elberg at the 2016 ESC Congress
An interview with Dr Jay Elberg (Head of Cardiovascular Development, Stanford) at the 2016 European Society of Cardiology Congress, Rome, Italy.
Cardiology
27 Sep 2016
An interview with Dr Rahul Potluri at the 2016 ESC Congress
An interview with Dr Rahul Potluri (ACALM Study Unit, Aston Medical School) at the 2016 European Society of Cardiology Congress, Rome, Italy.
Cardiology
27 Sep 2016
Congress Review – ESC 2016
Don’t miss our congress review in our EMJ Cardiology 4.1 2016 eJournal, coming soon…
Respiratory
27 Sep 2016
An interview with Dr Oliver Eickelberg at the 2016 ERS Congress
An interview with Dr Oliver Eickelberg (Chairman, Comprehensive Pneumology Center) at the 2016 European Respiratory Society Congress, London, United…
Respiratory
27 Sep 2016
An interview with Prof Nicholas Hill at the 2016 ERS Congress
An interview with Prof Nicholas Hill (Professor of Medicine, Tufts University) at the 2016 European Respiratory Society Congress, London, United Kingdom.
Respiratory
27 Sep 2016
Congress Review – ERS 2016
Don’t miss our congress review in our EMJ Respiratory 4.1 2016 eJournal, available now at: https://www.emjreviews.com/therapeutic-area/respiratory/
Neurology
19 Jul 2016
The Role of IL-6 in Autoimmune Disease
Rheumatoid arthritis, or RA, is an incompletely understood disorder. The complex pathophysiology of RA is regulated in part by a network of different…
Oncology
17 Jun 2016
Personalised screening for breast cancer care
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Andrew Evans, MRCP, FRCR, from…
Neurology
14 Jun 2016
EAN 2016 – Prof Günther Deuschl
Prof Gunther Deuschl’s press conference at EAN 2016.EMJ Neurology 4.1 2016 coming soon, subscribe for free today!
Neurology
14 Jun 2016
EAN 2016 – Prof John England – Part 2
Part 2 of Prof Raad Shakir’s & Prof John England’s press conference on ‘Neurological expertise and the Zika epidemic – Europe needs to get prepared for…
Neurology
14 Jun 2016
EAN 2016 – Prof Raad Shakir – Part 1
Part 1 of Prof Raad Shakir’s & Prof John England’s press conference on ‘Neurological expertise and the Zika epidemic – Europe needs to get prepared for…
Neurology
14 Jun 2016
EAN 2016 – Prof Mads Henrik Ravnborg
Prof Mads Henrik Ravnborg’s press conference at EAN 2016. EMJ Neurology 4.1 2016 coming soon, subscribe for free today!
Neurology
14 Jun 2016
EAN 2016 – Prof Franz Fazekas
Prof Franz Fazekas’s press conference at EAN 2016. EMJ Neurology 4.1 2016 coming soon, subscribe for free today!
Neurology
14 Jun 2016
EAN 2016 – Prof Gunhild Waldemar
Prof Gunhild Waldemar’s press conference at EAN 2016. EMJ Neurology 4.1 2016 coming soon, subscribe for free today!
Dermatology
14 Jun 2016
Overview of ZPL-3893787 (ZPL-389) clinical trial for atopic dermatitis
Thomas Werfel, MD, from Hannover Medical School, Hannover, Germany, gives an overview of a phase 2a proof-of-concept clinical trial evaluating ZPL…
Dermatology
14 Jun 2016
Phase 2a trial of ZPL-3893787 (ZPL-389), a histamine H4 receptor antagonist, for atopic dermatitis
Thomas Werfel, MD, from Hannover Medical School, Hannover, Germany, discusses the design and outcomes from a phase 2a proof-of-concept clinical trial…
Urology
14 Jun 2016
Innovation in Education – EAU 2016
Don’t miss our congress review in our EMJ Urology 4.1 2016 eJournal, available now…
Oncology
14 Jun 2016
Translating genomics to precision medicine for breast cancer care: Ongoing clinical studies
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Oleg Gluz, MD, from the West German…
Oncology
14 Jun 2016
Identifying breast cancer patients who can be spared chemotherapy, evidence from recent studies
The Oncotype DX® 21-gene Recurrence Score® result stratifies patients with breast cancer into low-, intermediate- and high-risk groups that correspond to…
Oncology
14 Jun 2016
Impact of phase 3 PlanB trial on evidence-based clinical practice for breast cancer
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Oleg Gluz, MD, from the West German…
Oncology
14 Jun 2016
5-year outcomes from PlanB: Phase 3 trial of 21-gene Recurrence Score® result in breast cancer
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Oleg Gluz, MD, from the West German…
Oncology
14 Jun 2016
Overview of prospective phase 3 PlanB trial of 21-gene Recurrence Score® result in breast cancer
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Oleg Gluz, MD, from the West German…
Urology
14 Jun 2016
An interview with Professor Theo M. de Reijke at the 2016 EAU Congress
An interview with Professor Theo M. de Reijke (Academic Medical Center, Amsterdam, Netherlands) at the 2016 European Association of Urology Congress…
Urology
14 Jun 2016
An interview with Doctor Evangelos Liatsikos at the 2016 EAU Congress
An interview with Doctor Evangelos Liatsikos (University of Patras, Patras, Greece) at the 2016 European Association of Urology Congress, Munich, Germany.
Urology
14 Jun 2016
An interview with Doctor Murat Arslan at the 2016 EAU Congress
An interview with Doctor Murat Arslan (Izmir University, Izmir, Turkey) at the 2016 European Association of Urology Congress, Munich, Germany.
Urology
14 Jun 2016
Congress Review – EAU 2016
Don’t miss our congress review in our EMJ Urology 4.1 2016 eJournal, available now at…
Urology
14 Jun 2016
Breast cancer in Europe: Epidemiology and outcomes
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Jan-Willem Coebergh, MD, PhD, from…
Oncology
14 Jun 2016
Defining factors that can predict neoadjuvant chemotherapy response in breast cancer
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Andrew Evans, MRCP, FRCR, from the…
Oncology
14 Jun 2016
Genetically determining susceptibility of breast cancer
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Douglas Easton, PhD, from the…
Oncology
14 Jun 2016
Surgical considerations after neoadjuvant treatment for breast cancer
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Isabel Rubio, MD, PhD, from Hospital…
Oncology
14 Jun 2016
Individualisation of breast cancer therapy
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Isabel Rubio, MD, PhD, from Hospital…
Hepatology
14 Jun 2016
ILC 2016 – Dr. James Freeman
Dr. James Freeman’s press conference on ‘High Sustained Virological Response Rates Using Direct Acting Antiviral Treatment For Hepatitis C, Imported Into…
Hepatology
14 Jun 2016
ILC 2016 – Dr. Stefano Brillanti
Dr. Stefano Brillanti’s press conference on ‘Development of Hepatocellular Carcinoma in HCV Cirrhotic Patients Treated with Direct Acting Antivirals’ at…
Hepatology
14 Jun 2016
ILC 2016 – Dr. Stephen Atkinson
Dr. Stephen Atkinson’s press conference on ‘A Genome-Wide Association Study Identifies PNPLA3 and SLC38A4 as Risk LOCI For Alcoholic Hepatitis’ at ILC 2016.
Hepatology
14 Jun 2016
Congress Review – ILC 2016
Don’t miss our congress review in our EMJ Hepatology 4.1 2016 eJournal, coming soon. Subscribe today at…
Hepatology
14 Jun 2016
An interview with Professor Jean-Francois Dufour at the 2016 ILC Congress
An interview with Professor Jean-Francois Dufour (University Clinic Visceral Surgery and Medicine, Bern, Switzerland) at the 2016 International Liver…
Hepatology
14 Jun 2016
An interview with Professor Marina Berenguer at the 2016 ILC Congress
An interview with Professor Marina Berenguer (University of Valencia, Valencia, Spain) at the 2016 International Liver Congress, Barcelona, Spain.
Hepatology
14 Jun 2016
An interview with Professor Cecilia Rodrigues at the 2016 ILC Congress
An interview with Professor Cecilia Rodrigues (University of Lisbon, Lisbon, Portugal) at the 2016 International Liver Congress, Barcelona, Spain.
Allergy & Immunology
14 Jun 2016
SUPREMO Trial: Pathology Quality Assurance
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Jeremy Thomas, MD, from…
Oncology
14 Jun 2016
Opportunities for improved outcomes in breast cancer patients
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Fatima Cardoso, MD, from…
Oncology
14 Jun 2016
2005–2015 global analysis of advanced breast cancer
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Fatima Cardoso, MD…
Oncology
14 Jun 2016
Imaging biomarkers as a predictive tool in breast cancer management
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Andrew Evans, MRCP, FRCR, from the…
Oncology
14 Jun 2016
Abstracts from the 10th European Breast Cancer Conference
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Fatima Cardoso, MD, from the…
Oncology
14 Jun 2016
Checkpoint inhibitors for triple-negative breast cancer
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Giuseppe Curigliano, MD, PhD, from…
Oncology
14 Jun 2016
Precision medicine for breast cancer
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Giuseppe Curigliano, MD, PhD, from…
Oncology
14 Jun 2016
Highlights of the 10th European Cancer Conference (EBCC-10) by Dr Giuseppe Curigliano
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Giuseppe Curigliano, MD, PhD, from…
Oncology
14 Jun 2016
Themes of the 10th European Breast Cancer Conference (EBCC-10)
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Fatima Cardoso, MD, from the…
Oncology
14 Jun 2016
Understanding the unique aspects of immunotherapy for lung cancer
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Martin Reck, MD, PhD, from the LungenClinic Grosshansdorf…
Oncology
14 Jun 2016
Immunotherapy for head and neck cancer
At the German Cancer Congress 2016, held in Berlin, Germany from 24 to 27 February 2016, Viktor Grünwald, MD, PhD, from Hannover Medical School, Hannover…
Oncology
14 Jun 2016
Improving the treatment of advanced renal cell carcinoma
At the German Cancer Congress 2016, held in Berlin, Germany from 24 to 27 February 2016, Viktor Grünwald, MD, PhD, from Hannover Medical School, Hannover…
Oncology
14 Jun 2016
Predictive biomarkers for immunotherapy in non-small cell lung cancer
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Martin Reck, MD, PhD, from the LungenClinic Grosshansdorf…
Oncology
14 Jun 2016
Next-generation sequencing to guide treatment decision-making
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Matthias Löhr, MD, PhD, from Karolinska Institutet, Stockholm…
Oncology
14 Jun 2016
Introducing next-generation sequencing into the clinical care of cancer
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Matthias Löhr, MD, PhD, from Karolinska Institutet, Stockholm…
Oncology
14 Jun 2016
Early versus delayed use of tyrosine kinase inhibitors for thyroid cancer
Recent advances in the biological understanding of thyroid cancer have led to the development of targeted therapies, such as the tyrosine kinase…
Oncology
14 Jun 2016
Updating the treatment algorithm for metastatic melanoma
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Axel Hauschild, MD, from University of Kiel, Kiel, Germany…
Oncology
14 Jun 2016
Changing the treatment landscape of metastatic melanoma
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Axel Hauschild, MD, from University of Kiel, Kiel, Germany…
Oncology
14 Jun 2016
Clinical decision-making for pancreatic cancer
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Thomas Seufferlein, MD, from University of Ulm, Ulm, Germany…
Oncology
14 Jun 2016
The significance of BRCA mutations in pancreatic cancer
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Thomas Seufferlein, MD, from University of Ulm, Ulm, Germany…
Oncology
14 Jun 2016
Treatment of pancreatic cancer: Overview of the continued progress
Pancreatic cancer is a leading cause of cancer-related deaths in developed countries. At the German Cancer Congress 2016, held in Berlin, Germany, from…
Hematology
13 Jun 2016
The DA-EPOCH-R clinical trial in Burkitt’s lymphoma
Jeremy Abramson, MD, from the Massachusetts General Hospital, Massachusetts, MA, gives an overview of the interim analysis of a multicenter prospective…
Oncology
25 May 2016
KEYNOTE-010: Pembrolizumab versus docetaxel in advanced PD-L1-positive NSCLC
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Solange Peters, MD, PhD…
Oncology
25 May 2016
ASCEND-2 and ASCEND-3 trials: Ceritinib in ALK-rearranged NSCLC with brain metastases
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Solange Peters, MD, PhD…
Oncology
25 May 2016
Immune checkpoint inhibitors, durvalumab plus tremelimumab, for non-small cell lung cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Solange Peters, MD, PhD…
Oncology
25 May 2016
Immunotherapy for hepatocellular carcinoma
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Su Pin Choo, MBBS…
Oncology
25 May 2016
Phase 3 LUX-H&N1 trial: Afatinib versus methotrexate for head and neck squamous cell carcinoma
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Makoto Tahara, MD…
Oncology
25 May 2016
Endocrine therapy in pregnant women with breast cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Sibylle Loibl, MD, PhD…
Oncology
25 May 2016
Olaparib and bevacizumab: On the horizon for treating ovarian cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Suresh Kumarasamy, MBBS…
Oncology
25 May 2016
Tumour biomarker changes after neoadjuvant chemotherapy in breast cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Sibylle Loibl, MD, PhD…
Oncology
25 May 2016
From biologics to biosimilars
A biosimilar can be defined as a biological product that demonstrates no clinically meaningful differences to an approved biological product. At the…
Rheumatology
19 Apr 2016
Treating Active HIDS with Canakinumab
The efficacy and safety of canakinumab in active hyperimmunoglobulinaemia D with periodic fever syndrome (HIDS) and the implications of the results for the future treatment of patients with the condition.
Rheumatology
19 Apr 2016
Pathophysiology and Treatment of HIDS
At the American College of Rheumatology Annual Meeting, topic of interest is the pathophysiology and treatment of the condition hyperimmunoglobulinaemia D with periodic fever syndrome (HIDS)
Oncology
19 Apr 2016
Canakinumab in the treatment of tumour necrosis factor receptor-associated periodic syndrome (TRAPS)
At the American College of Rheumatology Annual Meeting, which took place in San Francisco, California, USA, from 6 to 11 November 2015, Helen…
Rheumatology
19 Apr 2016
Treatment Strategies for TRAPS
At the American College of Rheumatology Annual Meeting, which took place in San Francisco, California, USA, from 6 to 11 November 2015, Helen Lachmann…
Rheumatology
19 Apr 2016
Treatments for Patients with CAPS
At the American College of Rheumatology Annual Meeting, which took place in San Francisco, California, USA, from 6 to 11 November 2015, Jasmin Kuemmerle…
Gastroenterology
12 Apr 2016
Discussion on mild and moderate IBD treatment led by Prof Geert D’Haens
Took place during the 11th Congress of ECCO.
Gastroenterology
12 Apr 2016
Success factors in the treatment of uncomplicated CD by Dr Pieter Hindryckx
Took place during the 11th Congress of ECCO. Dr Pieter Hindryckx, Department of Gastroenterology, University Hospital of Ghent, Ghent, Belgium considers…
Gastroenterology
12 Apr 2016
Success factors in the treatment of mild-to-moderate UC by Dr Ailsa Hart
Took place during the 11th Congress of ECCO. During this symposium Dr Ailsa Hart, Director, IBD Unit, St Mark’s Hospital, London, UK discusses the…
Oncology
9 Mar 2016
Precision medicine for metastatic breast cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Janice Tsang, MBBS…
Oncology
20 Feb 2016
Overview of a Phase I study of ONO/GS-4059 in relapsed and refractory mature B-cell malignancies
Martin JS Dyer, MA, DPhil, FRCP, FRCPath from the University of Leicester, Leicester, UK, provides an overview of a Phase I study of ONO/GS-4059, a…
Oncology
5 Feb 2016
Roles of targeted therapy and immunotherapy for gastrointestinal cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Atsushi Ohtsu, MD, PhD…
Oncology
5 Feb 2016
ESMO 2015 highlights: Putting ovarian cancer management into perspective
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Andrés Cervantes…
Oncology
5 Feb 2016
Defining ESMO Clinical Practice Guidelines at ESMO Asia 2015
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Andrés Cervantes, MD…
Oncology
5 Feb 2016
Phase 1b trial of durvalumab plus tremelimumab for advanced non-small cell lung cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Johan Vansteenkiste…
Oncology
5 Feb 2016
Update from CheckMate 057: Nivolumab versus docetaxel in advanced non-squamous NSCLC
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Johan Vansteenkiste, MD…
Oncology
5 Feb 2016
Therapeutic advances in immune checkpoint inhibitors for head and neck cancers
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Tanguy Seiwert, MD, from…
Oncology
5 Feb 2016
KEYNOTE-028: Phase 1b trial of pembrolizumab in PD-L1-positive nasopharyngeal carcinoma
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Tanguy Seiwert, MD, from…
Oncology
5 Feb 2016
LUX-H&N1: Phase 3 trial of afatinib versus methotrexate for head and neck squamous cell carcinoma
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Tanguy Seiwert, MD, from…
Oncology
5 Feb 2016
ESMO Clinical Practice Guidelines: Breast cancer case presentation
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Fatima Cardoso, MD, from…
Oncology
5 Feb 2016
Balancing therapeutics and patient access to new cancer drugs
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, ESMO and Congress…
Oncology
4 Feb 2016
Updates from CheckMate 017 and CheckMate 057: Nivolumab, anti-PD1, for non-small cell lung cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Martin Reck, MD, PhD…
Oncology
4 Feb 2016
Olaparib: An opportunity for personalised medicine in BRCA-related ovarian cancer
Recently, there have been numerous advances in the biological understanding of ovarian cancer. At the European Society for Medical Oncology (ESMO) Asia…
Oncology
4 Feb 2016
Optimising sequencing of new treatments for prostate cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Karim Fizazi, MD, PhD…
Oncology
4 Feb 2016
A new definition of genetic counselling for ovarian cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Jonathan A. Ledermann…
Oncology
4 Feb 2016
KEYNOTE-010: Pembrolizumab, anti-PD-1, for advanced NSCLC with PD-L1 expression
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Roy S. Herbst, MD, PhD…
Oncology
4 Feb 2016
Improving outcomes from advanced prostate cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Karim Fizazi, MD, PhD…
Oncology
4 Feb 2016
Cardio-oncology in multiple myeloma
Ola Landgren, MD, PhD from National Cancer Institute, Bethesda, MD talks about cardio-oncology in multiple myeloma (MM). In this new era of more…
Oncology
4 Feb 2016
Phase 3 trials of atezolizumab versus standard chemotherapy in PD-L1-selected NSCLC
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Roy S. Herbst, MD, PhD…
Oncology
4 Feb 2016
LUX-Lung 7: Phase 2b trial of afatinib versus gefitinib for EGFR-mutated adenocarcinoma of the lung
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Roy S. Herbst, MD, PhD…
Oncology
4 Feb 2016
AZD9291, an EGFR-TKI, for T790M-mediated resistance in non-small cell lung cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Pasi A. Jänne, MD, PhD…
Oncology
4 Feb 2016
LUX-Lung 7: Phase 2b trial of afatinib versus gefitinib for EGFR-mutated lung cancer in first-line
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Pasi A. Jänne, MD, PhD…
Oncology
4 Feb 2016
Oncogene-addicted non-small cell lung cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Pasi A. Jänne, MD, PhD…
Oncology
4 Feb 2016
Quality of life and new therapeutic options for metastatic castration-resistant prostate cancer
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Hilary Glen, MbChB, MSc, PhD, FRCP, of the Beatson West of Scotland Cancer…
Urology
3 Feb 2016
Potential Impact of New Techniques for Benign Prostatic Hyperplasia
An interview with Dr Ian Jackson (Consultant Anaesthetist, York Teaching Hospital NHS Foundation Trust) following the ‘GreenLight™ Laser System for Day…
Urology
3 Feb 2016
Transurethral Prostate Resection for Benign Prostatic Hyperplasia
An interview with Professor Andrea Tubaro (Depratment of Urology, Sant’Andrea Hospital, Sapienza University of Rome) following the ‘GreenLight™ Laser…
Urology
3 Feb 2016
GreenLight Laser Therapy for Benign Prostatic Hyperplasia
An interview with Mr Gordon Muir (Consultant Urological Surgeon, King’s College NHS Foundation Trust) following the ‘GreenLight™ Laser System for Day…
Oncology
2 Feb 2016
Learn more about the ESMO Asia 2015 Congress
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, ESMO and Congress…
Oncology
1 Feb 2016
Delivering the promise of immunotherapy for melanoma
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Peter Hersey, MD, PhD…
Gastroenterology
25 Jan 2016
An interview with Professor Geert D’Haens at the 23rd UEG Week
An interview with Professor Geert D’Haens (Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands) at the 23rd United European…
Urology
25 Jan 2016
Results of the GOLIATH Study
Professor Andrea Tubaro discusses the results of the GOLIATH study, which compared the Greenlight laser system with TURP in the treatment of benign…
Urology
25 Jan 2016
The Importance of Day-Case Surgery
Dr Ian Jackson describes the importance of day-care surgery for health service economies during the ‘GreenlightTM Laser System for Day-Case Surgery’s…
Oncology
25 Jan 2016
Q&A Session – Impact of the GreenLight Laser System for Day-Case Surgery
Mr Gordon Muir answers questions from the audience about the effect and impact of the Greenlight laser system for day-case surgery, which took place on…
Oncology
20 Jan 2016
Detailed timelines of cancer development
At the 2015 National Cancer Research Institute (NCRI) Cancer Conference, Peter Van Loo, PhD, from The Francis Crick Institute, London, UK, discusses the…
Oncology
20 Jan 2016
Lifestyle behaviour and cancer prevention
Eileen Kaner, MSc, PhD, Hon FRCP gives an overview of a session focusing lifestyle behaviour and cancer prevention presented at the 2015 National Cancer…
Oncology
20 Jan 2016
Trends in e-cigarette use in England
At the 2015 National Cancer Research Institute (NCRI) Cancer Conference, Robert West, PhD, from University College London, London, UK, discusses data…
Oncology
20 Jan 2016
Addressing the rapidly changing and diversifying educational needs of clinicians
At the 2015 National Cancer Research Institute (NCRI) Cancer Conference, Elaine Vickers, PhD, Founder and Principal Trainer of Science Communicated…
Respiratory
14 Jan 2016
Experts’ perspectives on the future of ASV therapy
‘Experts’ perspectives on the future of ASV therapy’ presented at the European Respiratory Society Congress (ERS) 2015, Amsterdam, Netherlands. Speakers…
Respiratory
14 Jan 2016
Detailed results of SERVE-HF and their implications
‘Detailed results of SERVE-HF and their implications’ presented at the European Respiratory Society Congress (ERS) 2015, Amsterdam, Netherlands. Speakers…
Oncology
13 Jan 2016
Cancer survivorship support in the UK and USA
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Rachael Crayton, Oncology Specialist Nurse from Central Manchester NHS Foundation Trust, Manchester, UK, discusses the highlighted key themes from a networking exercise with cancer survivorship programmes in the UK and USA that may be used to enhance these services for patients.
Oncology
13 Jan 2016
Evaluating genomic tests for breast cancer management
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Giampaolo Bianchini, MD, of the San Raffaele Scientific Institute, Milan, Italy…
Hematology
13 Jan 2016
Safety and Clinical Benefit of HSC Gene Therapy for Wiskott-Aldrich Syndrome
Press brief by Francesca Ferrua, MD, at the American Society of Hematology (ASH) 2015 annual meeting. Dr Ferrua provides an update on the safety and…
Hematology
13 Jan 2016
Lentiviral HSC Gene Therapy for Older Patients with X-Linked Severe Combined Immunodeficiency
Press brief by Suk See De Ravin, MD, PhD, at the American Society of Hematology (ASH) 2015 annual meeting. Dr De Ravin gives an overview of how…
Oncology
2 Jan 2016
Translating cancer immunotherapy to the clinic
At the 2015 National Cancer Research Institute (NCRI) Cancer Conference, Sergio Quezada, PhD, from University College London, London, UK, discusses…
Hematology
12 Dec 2015
Northstar study: gene therapy for beta-thalassemia major using LentiGlobin BB305 drug product
Press brief by Mark C. Walters, MD, at the American Socitety of Hematology (ASH) 2015 annual meeting. Dr Walters provides an update on the Northstar…
Hematology
12 Dec 2015
Infusion of allogeneic anti-CD19 CAR T-cells is a promising approach after alloHSCT
Press brief by James N. Kochenderfer, MD, at the American Socitety of Hematology (ASH) 2015 annual meeting. Dr Kochenderfer provides an overview of a…
Oncology
12 Dec 2015
Neutropenic sepsis: Medical alert bands in clinical practice
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Ruth Hammond, Vascular Access and IV Nurse Practitioner, and Clinical…
Oncology
12 Dec 2015
Effective control of chemotherapy-induced nausea and vomiting
Chemotherapy-induced nausea and vomiting (CINV) remains a concern for many cancer patients. At the United Kingdom Oncology Nursing Society (UKONS) Annual…
Oncology
12 Dec 2015
UKONS: Engaging the cancer nursing community in the UK
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Richard Henry, President Elect of the UKONS, and Teaching Fellow at the…
Oncology
12 Dec 2015
Myeloma education today
Myeloma UK provides information and support for individuals affected by multiple myeloma. At the United Kingdom Oncology Nursing Society (UKONS) Annual…
Oncology
12 Dec 2015
Out-of-hours support for cancer patients with a modified UKONS telephone triage tool
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Ali Hodge, Advanced Nurse Practitioner for Acute Oncology at The Royal…
Oncology
12 Dec 2015
Tenovus Cancer Care ‘Sing with Us’ choirs
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Rihannon Skilton, Head of Support Line Services, Tenovus Cancer Care…
Oncology
12 Dec 2015
UKONS: Bringing the nursing community together
Natalie Doyle, MSc, RGN, Nurse Consultant at The Royal Marsden NHS Foundation Trust, London, UK, discusses the aims of the United Kingdom Oncology…
Oncology
12 Dec 2015
Healthy lifestyle choices for patients with cancer
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Natalie Doyle, MSc, RGN, Nurse Consultant at The Royal Marsden NHS…
Oncology
12 Dec 2015
Drug development for metastatic castration-resistant prostate cancer
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Hilary Glen, MbChB, MSc, PhD, FRCP, of the Beatson West of Scotland Cancer…
Oncology
12 Dec 2015
Opportunities and challenges in immuno-oncology
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Toby Talbot, MB BS, of Royal Cornwall Hospitals NHS Trust, Truro, UK…
Oncology
12 Dec 2015
Defining patient safety at UKONS Annual Conference 2015
Richard Henry, President Elect of the United Kingdom Oncology Nursing Society (UKONS), and Teaching Fellow at the School of Nursing and Midwifery…
Oncology
12 Dec 2015
Motivational interviewing in healthcare
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Tim Anstiss, MB, MEd, D.Occ.Med, MFSEM, of the Academy for Health Coaching…
Oncology
12 Dec 2015
Prevention and treatment of chemotherapy-induced nausea and vomiting
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Richard Berman, MBBS, MRCGP, FRCP, of The Christie NHS Foundation Trust…
Oncology
12 Dec 2015
ManVan: Mobile cancer support for prostate, testicular and penile cancer
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Rihannon Skilton, Head of Support Line Services, Tenovus Cancer Care…
Oncology
12 Dec 2015
Evaluating the experience of surviving at least five years after a prostate cancer diagnosis
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Natalie Doyle, MSc, RGN, Nurse Consultant at The Royal Marsden NHS…
Oncology
11 Dec 2015
Improving adherence to oral therapies in clinical practice
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Cheryl Vidall, Head of Nursing and Governance at Alcura UK Limited, Alton…
Oncology
11 Dec 2015
Telephone assessment service for patients receiving ipilimumab for metastatic melanoma
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Joanne Upton, Skin Cancer Advanced Nurse Practitioner at The Clatterbridge…
Oncology
11 Dec 2015
Integrating psychological support and physical activity interventions in cancer care
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Margaret Oakes, Specialist Counselling Psychologist at Berkshire…
Oncology
11 Dec 2015
Improving survivorship services in haemato-oncology
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Michelle Taylor, Clinical Nurse Specialist, of The Great Western Hospital…
Oncology
11 Dec 2015
Optimising the assessment of sexuality in oncology
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Michael Mawhinney, doctoral research student, Oxford Brookes University…
Oncology
11 Dec 2015
A new model of care for lung cancer patients
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Lisa Wells, Macmillan Lung Cancer Clinical Nurse Specialist, of…
Oncology
11 Dec 2015
Developing a self-management programme to support prostate and testicular cancer survivors
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Andrew Turner, discusses a qualitative study of the self-management needs…
Oncology
11 Dec 2015
Defining the elements of the acute oncology nursing role
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Ali Hodge, Advanced Nurse Practitioner for Acute Oncology at The Royal…
Oncology
11 Dec 2015
Chemotherapy-induced nausea and vomiting – a nurse’s perspective
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Annie Young, SRN, PhD, Professor of Nursing, University of Warwick…
Oncology
11 Dec 2015
Physical activity, obesity and cancer
Martin Wiseman, MD talks about how the environment we live in determines the patterns of cancer across the world. There is now an increasingly large…
Oncology
11 Dec 2015
The use of supplements to complement a healthy and balanced diet for prostate cancer patients
Robert Thomas, MbChb, MRCP, MD, FRCR, discusses the results of the Pomi-T clinical trial. The study focused on the effects of Pomi-T on prostate-specific…
Oncology
11 Dec 2015
Strategies to cope with cancer therapy side-effects
Robert Thomas, MbChb, MRCP, MD, FRCR, discusses non-medicinal strategies to help cancer patients cope with cancer therapy side-effects. Prof. Robert…
Oncology
11 Dec 2015
The importance of a healthy and balanced diet for cancer patients
Robert Thomas, MbChb, MRCP, MD, FRCR, discusses the importance of having a healthy diet for cancer patients. Prof. Robert Thomas suggests that cancer…
Oncology
11 Dec 2015
Addressing patient safety at the UKONS Annual Conference 2015
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, which attracts cancer nurses from around the United Kingdom and beyond…
Oncology
11 Dec 2015
Molecular drivers of metastatic disease in breast cancer
At the European Cancer Congress (ECC) 2015, Giuseppe Curigliano, MD, PhD, of Istituto Europeo di Oncologia, Milan, Italy, explains that genetic…
Oncology
11 Dec 2015
Clinical implications of malnourishment in cancer care
At the European Cancer Congress (ECC) 2015, Riccardo A. Audisio, MD, FRCS, of the University of Liverpool, St. Helens Teaching Hospital, St. Helens, UK…
Oncology
11 Dec 2015
Nivolumab and cabozantinib versus standard of care in renal cell carcinoma
Thomas Powles, MBBS, MRCP, MD, of Barts and The London School of Medicine and Dentistry, London, UK, discusses the results of clinical trials reported…
Oncology
11 Dec 2015
Overcoming acquired resistance to targeted therapies in lung cancer
At the European Cancer Congress (ECC) 2015, David Ross Camidge, MD, PhD, of the University of Colorado Cancer Center, Aurora, CO, explains that…
Oncology
11 Dec 2015
The DETECT study: Personalised treatment in advanced breast cancer based on circulating tumour cells
At the European Cancer Congress (ECC) 2015, Wolfgang Janni, MD, PhD University Hospital Ulm, Ulm, discusses the interim analysis of the DETECT study…
Oncology
11 Dec 2015
The impact of the Oncotype DX® Breast Cancer Assay on the patient treatment journey
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Giampaolo Bianchini, MD, of the San Raffaele Scientific Institute, Milan, Italy…
Oncology
11 Dec 2015
ASPIRE-PCa: Prospective, global observational study of men with late-stage prostate cancer
At the European Cancer Congress (ECC) 2015, Maria De Santis, MD, of the University of Warwick, Warwick, UK, discusses the initial results of ASPIRE-PCa…
Oncology
11 Dec 2015
Seropositivity to tumour antigens as a potential new biomarker for melanoma relapse
At the European Cancer Congress (ECC) 2015, Paul Nathan, MB.BS, BSc (Hons), BA, PhD, FRCP, of Mount Vernon Cancer Centre, Northwood, UK, discusses a…
Oncology
11 Dec 2015
Biomarker-driven therapies for triple-negative breast cancer
At the European Cancer Congress (ECC) 2015, Giuseppe Curigliano, MD, PhD, of Istituto Europeo di Oncologia, Milan, Italy, discusses molecular subgroups…
Oncology
11 Dec 2015
Improving access to innovation in cancer care in Europe
At the European Cancer Congress (ECC) 2015, Matti Aapro, MD, of Clinique de Genolier, Genolier, Switzerland, describes the European School of Oncology…
Oncology
9 Dec 2015
Changing the standard of care in previously treated metastatic renal cell carcinoma
At the European Cancer Congress (ECC) 2015, Laurence Albiges, MD, of Institut Gustave Roussy, Villejuif, France, discusses the results of clinical trials…
Oncology
9 Dec 2015
POPLAR: Phase 2 trial of atezolizumab monotherapy in non-small cell lung cancer
At the European Cancer Congress (ECC) 2015, Johan Vansteenkiste, MD, PhD, of KU Leuven, Leuven, Belgium, discusses the primary analyses of efficacy…
Oncology
9 Dec 2015
Biomarker analysis of coBRIM: Phase 3 trial of cobimetinib plus vemurafenib for advanced melanoma
At the European Cancer Congress (ECC) 2015, Grant McArthur, MBBS, BMedSc, PhD, FRACP, of the Peter MacCallum Cancer Centre, Victoria, Australia…
Oncology
9 Dec 2015
AURELIA: Phase 3 trial of bevacizumab combined with chemotherapy for ovarian cancer
At the European Cancer Congress (ECC) 2015, Eric Pujade-Lauraine, MD, PhD, of Université Paris Descartes, Assistance Publique-Hôpitaux de Paris, Paris…
Oncology
9 Dec 2015
Deciding which of the available genomic tests to use
Multigene assays may provide clinically complementary information to classic clinicopathological tumour features, such as tumour size and grade, in…
Oncology
9 Dec 2015
Progress in the treatment of BRAF-mutant melanoma
At the European Cancer Congress (ECC) 2015, Dirk Schadendorf, MD, PhD, of Universitätsklinikum Essen, Essen, Germany, discusses the advances in the…
Oncology
9 Dec 2015
BIRCH: Phase 2 trial of atezolizumab for advanced PD-L1-selected non-small cell lung cancer
At the European Cancer Congress (ECC) 2015, Benjamin Besse, MD, PhD, of Institut Gustave Roussy, Villejuif, France, discusses BIRCH, a phase 2, single…
Oncology
9 Dec 2015
BELIEF: Phase 2 trial of erlotinib and bevacizumab in non-small cell lung cancer
At the European Cancer Congress (ECC) 2015, Bartomeu Massuti, MD, of Hospital General de Alicante, Alicante, Spain, discusses the Spanish Lung Cancer…
Oncology
9 Dec 2015
MASTERKEY-265: Phase 1b/3 trial of T-VEC and pembrolizumab for unresectable stage IIIB-IV melanoma
At the European Cancer Congress (ECC) 2015, Georgina Long, BSc, PhD, MBBS, FRACP, of The University of Sydney, Sydney, Australia, discusses the safety…
Oncology
9 Dec 2015
Involving patients in the use of their data
Chris Carrigan of the National Cancer Intelligence Network (NCIN), discusses the uses of the enormous amount of data collected by NHS on a daily basis…
Oncology
9 Dec 2015
2015 NCRI Cancer Conference highlights and new NCRI initiatives
Karen Kennedy, PhD, Director of the National Cancer Research Institute (NCRI), gives an overview of the 2015 NCRI Cancer Conference. The conference…
Oncology
9 Dec 2015
Epigenetic targets in cancer
Kristian Helin, PhD gives an overview of his talk on epigenetic targets in cancer presented at the 2015 National Cancer Research Institute (NCRI) Cancer…
Oncology
9 Dec 2015
Breast Cancer Now: aiming to prevent death from breast cancer by 2050
Robert Coleman, MBBS, MD, FRCP, a trustee of Breast Cancer Now, discusses the goals of the newly formed charity that resulted from the combination of…
Innovations
9 Dec 2015
Is late diagnosis of cancer real and if so, what can we do about it?
Harpal Kumar, MA MEng MBA DSc gives an overview of his session at the 2015 National Cancer Research Institute (NCRI) Cancer Conference, where he…
Oncology
9 Dec 2015
Investigating the genomic landscape of brain tumours using metabolic imaging
Kevin Brindle, PhD gives an overview of his talk at the 2015 National Cancer Research Institute (NCRI) Cancer Conference, where he described a new…
Oncology
9 Dec 2015
Systematic assessment of patient and carer needs in the oncology clinical and GP surgery
Miriam Johnson, MD gives an overview of a session at at the 2015 National Cancer Research Institute (NCRI) Cancer Conference, that focuses on the…
Oncology
9 Dec 2015
How many cancers can we prevent through dietary modifications?
Paolo Boffetta, MD, MPH gives an overview of his talk at the 2015 National Cancer Research Institute (NCRI) Cancer Conference. In his talk he discusses…
Oncology
9 Dec 2015
Molecular testing for early cancer diagnosis: ready for prime time
Rebecca Fitzgerald, MD, FAAD gives an overview of a session presented at the 2015 National Cancer Research Institute (NCRI) Cancer Conference, focusing…
Oncology
9 Dec 2015
The origins of CDK by Tim Hunt
Tim Hunt, FRS, FMedSci describes the path that led him to identify cyclin-dependent kinases (CDK), along with colleagues Paul Nurse and Leland Hartwell…
Oncology
9 Dec 2015
Chemoprevention in breast cancer
Jack Cuzick, PhD, FMedSci, FRCP(hon), of the Queen Mary University of London, UK gives an overview of the session ‘Prevention is better than cure’…
Oncology
9 Dec 2015
Tumour: stroma interactions
In the session ” Tumour: stroma interactions” presented at the 2015 National Cancer Research Institute (NCRI) Cancer Conference, the importance of…
Diabetes
1 Dec 2015
Should Type 2 Diabetes Management Be More of a Priority in Post-Acute Coronary Syndrome Patients?
A full recording of the Takeda-sponsored symposium held at the 51st Annual Meeting of the European Association for the Study of Diabetes in Stockholm…
Diabetes
26 Nov 2015
Optimal Management of Post-ACS T2D Patients: Panel Discussion
Prof Jean-Claude Tardif, Prof Stephen Nicholls, Prof Jørgen Rungby, and Prof Faiez Zannad respond to audience questions in a Q&A session chaired by Prof…
Diabetes
26 Nov 2015
The ACS Patient Journey: Where Does T2 Diabetes Fit In?
At a Takeda-sponsored symposium held at the 51st Annual Meeting of the European Association for the Study of Diabetes in Stockholm, Sweden, on the 14th…
Diabetes
26 Nov 2015
What Do We Know About the Safety of OADs in Post-ACS Patients? Exploring Evidence from Recent Outcomes Studies
At a Takeda-sponsored symposium held at the 51st Annual Meeting of the European Association for the Study of Diabetes in Stockholm, Sweden, on the 14th…
Diabetes
26 Nov 2015
Diabetologist’s Perspective of Diabetes and Cardiovascular Risk Management in Post-ACS T2D patients
At a Takeda-sponsored symposium held at the 51st Annual Meeting of the European Association for the Study of Diabetes in Stockholm, Sweden, on the 14th…
Diabetes
26 Nov 2015
Cardiologist’s Perspective of Diabetes and Cardiovascular Risk Management in Post-ACS T2D patients
At a Takeda-sponsored symposium held at the 51st Annual Meeting of the European Association for the Study of Diabetes in Stockholm, Sweden, on the 14th…
Diabetes
26 Nov 2015
Should Type 2 Diabetes Management Be More of a Priority in Post-Acute Coronary Syndrome Patients? Opening Remarks
Prof Ele Ferrannini of the University of Pisa School of Medicine, Pisa, Italy, welcomes congress delegates to a Takeda-sponsored symposium held at the…
Oncology
19 Nov 2015
Genomics England: 100,000 Genomes Project
Clare Turnbull, MD, PhD, gives an overview of her talk at the 2015 National Cancer Research Institute (NCRI) Cancer Conference, where the Genomics…
Oncology
19 Nov 2015
Reducing prostate cancer progression and mortality: what patients can do to reduce risk
Stacey Kenfield, DSc gives an overview of her talk at the 2015 National Cancer Research Institute (NCRI) Cancer Conference. Dr Kenfield talks about how…
Oncology
19 Nov 2015
Helping healthcare professionals initiate conversations about physical activity
At the 2015 National Cancer Research Institute (NCRI) Cancer Conference, Justin Webb talks about the initiatives Macmillan Cancer Support is implementing…
Oncology
19 Nov 2015
Keeping active with Macmillan Cancer Support
At the 2015 National Cancer Research Institute (NCRI) Cancer Conference, Justin Webb gives an overview of a new Macmillan Cancer Support initiative aimed…
Oncology
19 Nov 2015
Physical activity – the panacea?
Robert Thomas, MbChb, MRCP, MD, FRCR, gives an overview of the session “Physical activity – the panacea?” at the 2015 National Cancer Research Institute…
Oncology
19 Nov 2015
The development of genomic tests and how validation affects their use in the clinic
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Giampaolo Bianchini, MD, of the San Raffaele Scientific Institute, Milan, Italy…
Oncology
19 Nov 2015
2015 NCRI Cancer Conference: Francis Crick Institute scientists
Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research UK London Research Institute, London, UK, discusses topics covered…
Oncology
19 Nov 2015
Clonal evolution in colorectal cancer
At the 2015 National Cancer Research Institute (NCRI) Cancer Conference, Alberto Bardelli, PhD talks about clonal evolution in colorectal cancer. He also…
Oncology
19 Nov 2015
Update on CheckMate 067, an advanced melanoma clinical trial
James Larkin, MD, PhD gives an update on the clinical trial CheckMate 067, a phase 3 study of Nivolumab or Nivolumab plus Ipilimumab versus Ipilimumab…
Oncology
19 Nov 2015
Physical activity levels and barriers to exercise referral among patients with cancer
Dorothy Yang gives an overview of a study assessing the physical activity levels and barriers to exercise referral among patients with cancer, at the…
Oncology
19 Nov 2015
2015 NCRI Cancer Conference: Featured sessions
Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research UK London Research Institute, London, UK, gives an overview of the…
Oncology
19 Nov 2015
2015 NCRI Cancer Conference: The highlights
Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research UK London Research Institute, London, UK, gives an overview of the…
Oncology
19 Nov 2015
Current status and future prospective of Trial Assigning IndividuaLized Options for Treatment (Rx)
At the European Cancer Congress (ECC) 2015, André Robidoux, MD, FRCSC, of Centre Hospitalier de l’Université de Montréal, Montreal, Canada, discusses…
Oncology
23 Oct 2015
Results and impact of TAILORx: Trial Assigning IndividuaLized Options for Treatment (Rx)
At the European Cancer Congress (ECC) 2015, André Robidoux, MD, FRCSC, of Centre Hospitalier de l’Université de Montréal, Montreal, Canada, discusses…
Oncology
23 Oct 2015
Immunotherapy: Targeting tumour heterogeneity
At the European Cancer Congress (ECC) 2015, Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research UK London Research…
Oncology
15 Oct 2015
New approaches to molecular cancer therapeutics
At the European Cancer Congress (ECC) 2015, Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research UK London Research…
Oncology
15 Oct 2015
The Patient Reported Opinions about Clinical Tolerability (PROACT)
At the European Cancer Congress (ECC) 2015, Hendrik-Tobias Arkenau, MD, PhD, of Sarah Cannon Research Institute UK, London, UK, discusses Patient…
Oncology
15 Oct 2015
EURECCA international comparison of treatment patterns for non-metastatic breast cancer
At the European Cancer Congress (ECC) 2015, Riccardo A. Audisio, MD, FRCS, of the University of Liverpool, St. Helens Teaching Hospital, St. Helens, UK…
Oncology
15 Oct 2015
Results from the ETOP Lungscape Project: Multiplex mutation testing in NSCLC
At the European Cancer Congress (ECC) 2015, Keith M. Kerr, BSc, MB, ChB, FRCPath, FRCPE, of the University of Aberdeen, Aberdeen, Scotland, discusses the…
Oncology
15 Oct 2015
The causes and consequences of tumour evolution and heterogeneity
At the European Cancer Congress (ECC) 2015, Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research UK London Research…
Oncology
15 Oct 2015
Patient-centered partnership improve access to optimal standards of cancer care in Europe
European Cancer Patient Coalition (ECPC) is the largest European cancer patients’ umbrella organisation, representing 365 patient organisations in 40…
Oncology
15 Oct 2015
ECC 2015: Press programme with updates on ‘Europe of Disparities in Cancer’
At the European Cancer Congress (ECC) 2015, Mark Lawler, PhD, of Queen’s University Belfast, Belfast, UK, Richard Sullivan, MD, PhD, of King’s College…
Oncology
15 Oct 2015
The discovery of new biomarkers for predicting outcomes in breast cancer
In patients with early stage breast cancer, there is a need to identify prognostic factors to determine the risk of recurrence and predictive factors to…
Oncology
15 Oct 2015
First-in-human study of first-in-class fatty acid synthase inhibitor, TVB-2640
At the European Cancer Congress (ECC) 2015, Hendrik-Tobias Arkenau, MD, PhD, of Sarah Cannon Research Institute UK, London, UK, discusses a first-in…
Oncology
15 Oct 2015
Exploratory analysis of frontline therapies in REVEL: A phase 3 trial of ramucirumab in NSCLC
At the European Cancer Congress (ECC) 2015, Giorgio V. Scagliotti, MD, PhD, of the University of Turin, Turin, Italy, discusses the exploratory analysis…
Oncology
15 Oct 2015
ECC 2015: News briefing chaired by Prof Peter Naredi
At the European Cancer Congress (ECC) 2015, Peter Naredi, MD, PhD, of the University of Gothenburg, Gothenburg, Sweden, chairs a news briefing with…
Oncology
15 Oct 2015
Phase 2 trial of TAK-385, an oral GnRH antagonist, in prostate cancer
At the European Cancer Congress (ECC) 2015, Neal Shore, MD, FACS, of Carolina Urologic Research Center, Myrtle Beach, SC, discusses the first interim…
Oncology
15 Oct 2015
ECC 2015: Cancer healthcare inequalities between and within countries in Europe
There is a growing divide in cancer healthcare and survivorship between populations across Europe. European Cancer Patient Coalition (ECPC), the largest…
Oncology
15 Oct 2015
TAILORx: Prospective phase 3 trial validating a 21-gene expression assay in breast cancer
At the European Cancer Congress (ECC) 2015, Clifford A. Hudis, MD, of Memorial Sloan Kettering Cancer Center, New York, NY, discusses the low-risk…
Oncology
15 Oct 2015
ECC 2015: Challenging the European disparities in cancer care
European Cancer Patient Coalition (ECPC), the largest European cancer patients’ umbrella organisation, presented the paper, ‘Europe of Disparities in…
Oncology
15 Oct 2015
ECC 2015: Hormonal therapy may prevent ovarian failure and preserve fertility in breast cancer
A meta-analysis was conducted to include 12 randomised trials and a total of 1,231 breast cancer patients receiving chemotherapy, with or without…
Oncology
15 Oct 2015
Clinical access to genomic information in Europe
Genomic interventions may improve disease-risk stratification and patient-tailored treatment. At the European Cancer Congress (ECC) 2015, John Crown, MD…
Oncology
14 Oct 2015
Results and impact of TAILORx: Trial Assigning IndividuaLized Options for Treatment (Rx)
At the European Cancer Congress (ECC) 2015, John Crown, MD, MBA, of St Vincent’s University Hospital, Dublin, Ireland, discusses the low-risk registry…
Oncology
14 Oct 2015
Phase 1b trial of avelumab in advanced gastric or gastroesophageal junction cancer
At the European Cancer Congress (ECC) 2015, Hendrik-Tobias Arkenau, MD, PhD, of Sarah Cannon Research Institute UK, London, UK, discusses a phase 1b…
Oncology
14 Oct 2015
ECC 2015: Post-diagnosis aspirin improves survival in gastrointestinal cancers
Results from a study in The Netherlands involving 13,715 patients showed that aspirin use after a cancer diagnosis significantly improved overall…
Oncology
14 Oct 2015
ECC 2015: New survival data from Combi-v trial of combination of two targeted therapies in melanoma
Updated results from the phase 3 COMBI-v trial of a combination of dabrafenib and trametinib for the first-line treatment of patients with…
Oncology
14 Oct 2015
ECC 2015: NETTER-1 trial showed rare cancer responded unusually well to new treatment
NETTER-1, a phase 3 clinical trial, evaluated Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTATATE in patients with Grade 1–2 metastatic…
Oncology
14 Oct 2015
ECC 2015: RADIANT-4 trial showed promise in the treatment of neuroendocrine tumours
RADIANT-4, a placebo-controlled, double-blind, phase 3 clinical trial conducted in centres in 13 European countries, Korea, Japan, Canada, and the US…
Oncology
14 Oct 2015
ECC 2015: Launch of the European Society for Paediatric Oncology (SIOPE) strategic plan
The European Society for Paediatric Oncology (SIOP Europe or SIOPE), is a pan-European organisation that represents professionals working in the field…
Oncology
14 Oct 2015
ECC 2015: News briefing chaired by Prof Martine Piccart
At the European Cancer Congress (ECC) 2015, Martine Piccart, MD, PhD, of Université Libre de Bruxelles and Institut Jules Bordet, Brussels, Belgium…
Oncology
14 Oct 2015
ECC 2015: CheckMate 025 trial showed nivolumab improved overall survival in advanced kidney cancer
CheckMate 025, a phase 3 clinical trial, compared the anti-programmed cell death protein-1 (PD-1) antibody, nivolumab, with the standard treatment…
Oncology
14 Oct 2015
ECC 2015: EUROCARE-5 trial showed large variations in blood cancer survival in Europe
Comparisons of cancer patients’ survival and care in Europe up to 2007 showed that although more patients are surviving for at least five years after…
Oncology
14 Oct 2015
ECC 2015: METEOR trial showed cabozantinib improved survival in advanced kidney cancer
METEOR, a phase 3 clinical trial, compared cabozantinib with everolimus for the treatment of patients with advanced clear cell renal cell carcinoma.
Oncology
14 Oct 2015
The value of an intermediate Recurrence Score® result in the Oncotype DX® Breast Cancer Assay
The Oncotype DX® Breast Cancer Assay is a 21-gene assay that provides a Recurrence Score® (RS), which is divided into low-, intermediate- and high-risk…
Oncology
14 Oct 2015
TERRAIN trial of enzalutamide versus bicalutamide for advanced prostate cancer
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Neal Shore, MD, FACS, of Atlantic Urology Clinics, Myrtle Beach, SC…
Oncology
14 Oct 2015
Assessing the eligibility of a breast cancer patient for genomic testing
Genomic tests, such as the Oncotype DX® Breast Cancer Assay, provide results that quantify recurrence risk and identify patients who are likely or…
Oncology
14 Oct 2015
Updated results of a phase 1a study of anti-PDL1, MPDL3280A, in urothelial bladder cancer
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Thomas Powles, MBBS, MRCP, MD, of Barts Cancer Institute, Queen Mary University…
Oncology
14 Oct 2015
Experience of the Oncotype DX® Breast Cancer Assay in the clinic
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Harold J. Burstein, MD, PhD, of Dana-Farber Cancer Institute, Boston, MA…
Oncology
15 Sep 2015
Genomic testing for breast cancer in the neoadjuvant setting
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Hope S. Rugo, MD, of the UCSF Helen Diller Family Comprehensive Cancer Center…
Oncology
15 Sep 2015
Introducing the Oncotype DX® Breast Cancer Assay and its impact in clinical practice
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Mohammed Jaloudi, MD, of Tawam Hospital, Al Ain, United Arab Emirates, discusses…
Oncology
15 Sep 2015
The use of Ki-67, a proliferation marker, for guiding treatment decisions in breast cancer patients
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Joseph Gligorov, MD, PhD, of Sorbonne Université, Paris, France, discusses some…
Oncology
15 Sep 2015
Introducing the Oncotype DX® Breast Cancer Assay in the clinic
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Harold J. Burstein, MD, PhD, of Dana-Farber Cancer Institute, Boston, MA…
Oncology
15 Sep 2015
Refining the therapeutic approach for breast cancer through genomic profiling
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Mohammed Jaloudi, MD, of Tawam Hospital, Al Ain, United Arab Emirates, discusses…
Oncology
15 Sep 2015
Considerations when selecting a genomic test to use in specific breast cancer patients
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Hope S. Rugo, MD, of the UCSF Helen Diller Family Comprehensive Cancer Center…
Oncology
9 Sep 2015
Genomic profiling for defining luminal subtypes
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Harold J. Burstein, MD, PhD, of Dana-Farber Cancer Institute, Boston, MA…
Oncology
9 Sep 2015
Using genomic testing to access the suitability of breast cancer patients for chemotherapy
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Joseph Gligorov, MD, PhD, of Sorbonne Université, Paris, France, discusses the…
Oncology
26 Aug 2015
Registry evaluating the impact of genomic testing on treatment of prostate cancer patients
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Neal Shore, MD, FACS, of Atlantic Urology Clinics, Myrtle Beach, SC, discusses…
Oncology
26 Aug 2015
CancerLinQ: ASCO’s initiative to improve patient care through big data
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Julie M. Vose, MD, MBA, of the University of Nebraska Medical Center, Omaha, NE…
Oncology
26 Aug 2015
ARAMIS trial of ODM-201 for high-risk non-metastatic castration-resistant prostate cancer
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Neal Shore, MD, FACS, of Atlantic Urology Clinics, Myrtle Beach, SC, discusses…
Oncology
26 Aug 2015
Immune checkpoint inhibitors and biomarker-driven strategies for managing lung cancer
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Keith Kerr, BSc, MB, ChB, FRCPath, FRCPE, of the University of Aberdeen…
Oncology
26 Aug 2015
An update on the treatment of chronic lymphocytic leukaemia
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Stephan Stilgenbauer, MD, of Ulm University, Ulm, Germany, reviews the changing…
Oncology
26 Aug 2015
HELIOS: Phase 3 trial of ibrutinib with bendamustine and rituximab for relapsed/refractory CLL
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Jacqueline Barrientos, MD, of North Shore-LIJ Cancer Institute, Lake Success, NY…
Oncology
26 Aug 2015
IMAAGEN: Phase 2 trial of abiraterone acetate for advanced prostate cancer
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Neal Shore, MD, FACS, of Atlantic Urology Clinics, Myrtle Beach, SC, provides…
Oncology
26 Aug 2015
CheckMate 067: Combined nivolumab and ipilimumab or monotherapy in untreated melanoma
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Paolo A. Ascierto, MD, of Istituto Nazionale Tumori IRCCS “Fondazione G. Pascale…
Oncology
26 Aug 2015
The evolving role of chemotherapy for the management of advanced prostate cancer
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Karim Fizazi, MD, PhD, of the Institut Gustave Roussy, Villejuif, France…
Oncology
26 Aug 2015
Daratumumab for heavily pretreated multiple myeloma
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Sagar Lonial, MD, of the Winship Cancer Institute, Emory University, Atlanta…
Oncology
26 Aug 2015
Current clinical perspectives on targeted therapy and immunotherapy for melanoma
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Caroline Robert, MD, PhD, of Institut Gustave Roussy, Villejuif, France…
Oncology
26 Aug 2015
ENDEAVOR: Phase 3 trial comparing carfilzomib versus bortezomib in relapsed multiple myeloma
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Joseph R. Mikhael, MD, of Mayo Clinic, Scottsdale, AZ, discusses the…
Oncology
26 Aug 2015
Phase 2 trial of lenvatinib and everolimus for metastatic renal cell carcinoma
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Sumanta K. Pal, MD, of City of Hope Comprehensive Cancer Center, Duarte, CA…
Oncology
26 Aug 2015
Frontline and relapsed treatment of follicular lymphoma
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting Jeremy S. Abramson, MD, of the Massachusetts General Hospital Cancer Center…
Oncology
26 Aug 2015
The Conquer Cancer Foundation of the American Society of Clinical Oncology
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Julie M. Vose, MD, MBA, FASCO, of the University of Nebraska Medical Center…
Oncology
26 Aug 2015
Evaluating sustained adherence to ibrutinib in previously treated CLL
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Jacqueline Barrientos, MD, of North Shore-LIJ Cancer Institute, Lake Success…
Oncology
21 Aug 2015
Therapy for newly diagnosed patients with mantle cell lymphoma
At the 20th Congress of the European Hematology Association (EHA), Marek Trněný, MD, PhD, of Charles University, Prague, Czech Republic, discusses new…
Oncology
21 Aug 2015
Introducing biomarkers for the management of patients with prostate cancer
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Eleni Efstathiou, MD, PhD, of The University of Texas MD Anderson Cancer Center…
Oncology
21 Aug 2015
CALGB 49907 trial: Standard chemotherapy versus capecitabine for older women with breast cancer
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Hyman Muss, MD, of the University of North Carolina, Chapel Hill, NC, provides…
Oncology
21 Aug 2015
Developing targeted therapies for melanoma
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Georgina Long, BSc, PhD, MBBS, FRACP, of the University of Sydney, Sydney…
Nephrology
13 Aug 2015
Bruce Culleton: The Latest Developments in Home Dialysis
An interview with Dr Bruce Culleton discussing HOMECHOICE CLARIA, SHARESOURCE and VIVIA at ERA-EDTA 2015.
Oncology
13 Aug 2015
Predicting late recurrence of breast cancer
At the 14th St. Gallen International Breast Cancer Conference 2015, Eleftherios P. Mamounas, MD, of University of Florida Health Cancer Center-Orlando…
Oncology
13 Aug 2015
The management of breast cancer in the Japanese population
At the 14th St. Gallen International Breast Cancer Conference 2015, Masakazu Toi, MD, PhD, of Kyoto University, Japan, explains that there are still only…
Hematology
13 Aug 2015
New therapeutic approaches for Hodgkin lymphoma
At the 20th Congress of the European Hematology Association (EHA), Andrew Davies, BSc (Hons), BM (Hons), MRCP, PhD, of the University of Southampton…
Hematology
13 Aug 2015
Novel monoclonal antibody-based therapies for multiple myeloma
At the 20th Congress of the European Hematology Association (EHA), Sagar Lonial, MD, of the Winship Cancer Institute, Emory University, Atlanta, GA…
Oncology
13 Aug 2015
Borealis-1™: Phase 2 trial of gemcitabine/cisplatin plus apatorsen in advanced bladder cancer
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Sumanta K. Pal, MD, of City of Hope Comprehensive Cancer Center, Duarte, CA…
Rheumatology
27 Jul 2015
Interview with Prof. Iain McInnes at EULAR 2015
Interview with Prof. Iain McInnes at the European League Against Rheumatism (EULAR) 2015 discussing his research on spondyloarthritis.
Oncology
23 Jul 2015
PERSIST-2: Phase 3 trial of pacritinib versus best available therapy for myelofibrosis
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Ruben A. Mesa, MD, of Mayo Clinic, Arizona, TX, discusses the ongoing PERSIST-2…
Oncology
23 Jul 2015
Emerging immunotherapies for kidney cancer
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Thomas Powles. MBBS, MRCP, MD, of Barts Cancer Institute, Queen Mary University…
Oncology
23 Jul 2015
Phase 3 COMBI-d trial of dabrafenib plus trametinib in metastatic
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Hendrik-Tobias Arkenau, MD, PhD, of Sarah Cannon Research Institute, London, UK…
Oncology
23 Jul 2015
ARAMIS: Phase 3 trial of ODM-201 for high-risk non-metastatic castration-resistant prostate cancer
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Karim Fizazi, MD, PhD, of the Institut Gustave Roussy, Villejuif, France…
Loading posts...
« Previous
1
…
72
73
74
75
76
…
89
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View